Results 231 to 240 of about 148,095 (306)

Examining APOE ε4 and Longitudinal Vascular Brain Injury: The Strong Heart Study. [PDF]

Neurol Open Access
Hayes CA, Odden MC, Levendovszky SR, Buchwald DS, Verney S, Shibata DK, Zhang Y, Ali T, Suchy-Dicey AM.   +8 more
europepmc   +1 more source

Autism Screening in the First Year and Beyond: Comparison of Multiple Measures

Autism Research, EarlyView.
ABSTRACT Autism screening aids in early detection and diagnosis. Several screeners are available for toddlers 16 months and older, but there is little data on the accuracy of screening measures used in the first year of life. A community sample (N = 1641) completed three screeners—M‐CHAT‐R, ITC, VIRSA—online at 6, 9, 12, 18, and 24 months of age ...
Devon N. Gangi, Chandni Parikh, Monique Moore Hill, Shyeena Maqbool, Rachel Ni, Simon Dvorak, Gregory S. Young, Sally Ozonoff   +7 more
wiley   +1 more source

Population pharmacokinetics and pharmacodynamics of canagliflozin in paediatric patients with type 2 diabetes mellitus

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Canagliflozin was recently approved in type 2 diabetes mellitus (T2DM) patients ≥10 and <18 years old as a single agent dosed once daily (QD) or in a fixed‐dose combination with metformin dosed twice daily (BID). We characterize canagliflozin pharmacokinetics in paediatric patients with T2DM, compare estimated individual and simulated ...
Nele Goeyvaerts, Per Olsson Gisleskog, Martine Neyens, Juan José Perez Ruixo, Saberi Rana Ali, Iolanda Cirillo, Oliver Ackaert   +6 more
wiley   +1 more source

A hybrid BiLSTM and rule-based system for integrated diabetes prediction and personalized guidance. [PDF]

PLoS One
Saleem M, Hamid M, Malik S.
europepmc   +1 more source

Model‐informed optimal dose selection of golcadomide in combination with R‐CHOP in patients with previously untreated aggressive B‐cell lymphoma

British Journal of Clinical Pharmacology, EarlyView.
Aims Golcadomide is a potential first‐in‐class oral CELMoD™ agent for the treatment of lymphoma. This study aims to develop model‐informed drug development (MIDD) approaches to support optimal dose selection of golcadomide in combination with immunotherapy rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R‐CHOP) in alignment with ...
Xirong Zheng, Zhiling Yu, Mark Kaplan, Argyrios Gkasiamis, Akshay Sudhindra, Li Zhu, Manisha Lamba, Fan Wu   +7 more
wiley   +1 more source

Childhood Trauma and Adult Loneliness as Predictors of Sleep Health in Blackfeet American Indian Adults. [PDF]

Int J Behav Med
Hutchison M, Henderson-Matthews B, Wood ZJ, Kothe R, Runner GH, Johnson Iii L, Lafromboise ME, Malatare M, Salois E, Carter JR, Helm P, John-Henderson NA.   +11 more
europepmc   +1 more source

Correction: Rural-urban differences in lipid abnormalities among middle‑aged and older Indians. [PDF]

BMC Public Health
Chatterjee P, Arora S, Rai P, Diwakar L, Issac TG, Sundarakumar JS.   +5 more
europepmc   +1 more source

Nutritional considerations for glucagon-like peptide-based therapies: An Asian Indian consensus recommendation. [PDF]

Obes Pillars
Joshi SR, Misra A, Mithal A, Saboo B, Seshadri KG, Chowdhury S, Bantwal G, Sethi B, Kesavadev J, Bhattacharya AD, Baruah MP, Budhwar A, Thakor P, Shende S, Mohan V.   +14 more
europepmc   +1 more source

Diabetes Genetic Clusters and Clinical Outcomes in American Indians. [PDF]

Diabetes
Reynolds KM, Sun Q, Zhang Y, Umans J, Cole SA, Morris AP, Franceschini N, Franceschini N.   +7 more
europepmc   +1 more source